Hisham Mehanna
Hisham Mehanna
Director and Professor, Institute of head and Neck Studies and Education, Uni of Birmingham
Verified email at - Homepage
Cited by
Cited by
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region
H Mehanna, T Beech, T Nicholson, I El‐Hariry, C McConkey, V Paleri, ...
Head & neck 35 (5), 747-755, 2013
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...
The Lancet 393 (10166), 51-60, 2019
Refeeding syndrome: what it is, and how to prevent and treat it
HM Mehanna, J Moledina, J Travis
Bmj 336 (7659), 1495-1498, 2008
HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients
X Castellsagué, L Alemany, M Quer, G Halec, B Quirós, S Tous, ...
Journal of the National Cancer Institute 108 (6), djv403, 2016
PET-CT surveillance versus neck dissection in advanced head and neck cancer
H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...
New England Journal of Medicine 374 (15), 1444-1454, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ...
Journal for immunotherapy of cancer 7, 1-31, 2019
Treatment and follow‐up of oral dysplasia—a systematic review and meta‐analysis
HM Mehanna, T Rattay, J Smith, CC McConkey
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2009
Head and neck cancer—Part 1: Epidemiology, presentation, and prevention
H Mehanna, V Paleri, CML West, C Nutting
Bmj 341, 2010
A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or …
MG Isles, C McConkey, HM Mehanna
Clinical Otolaryngology 33 (3), 210-222, 2008
Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: the phase 2 CONDOR randomized clinical trial
LL Siu, C Even, R Mesía, E Remenar, A Daste, JP Delord, J Krauss, ...
JAMA oncology 5 (2), 195-203, 2019
Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 …
H Mehanna, T Al-Maqbili, B Carter, E Martin, N Campain, J Watkinson, ...
The Journal of Clinical Endocrinology & Metabolism 99 (8), 2834-2843, 2014
HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology
AG Schache, NG Powell, KS Cuschieri, M Robinson, S Leary, H Mehanna, ...
Cancer research 76 (22), 6598-6606, 2016
The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta‐analysis
MD Weller, PC Nankivell, C McConkey, V Paleri, HM Mehanna
Clinical otolaryngology 35 (5), 364-372, 2010
Biomarkers in dysplasia of the oral cavity: a systematic review
J Smith, T Rattay, C McConkey, T Helliwell, H Mehanna
Oral oncology 45 (8), 647-653, 2009
Refeeding syndrome–awareness, prevention and management
H Mehanna, PC Nankivell, J Moledina, J Travis
Head & neck oncology 1, 1-5, 2009
Oropharyngeal carcinoma related to human papillomavirus
H Mehanna, TM Jones, V Gregoire, KK Ang
Bmj 340, 2010
Postoperative hypocalcemia—the difference a definition makes
HM Mehanna, A Jain, H Randeva, J Watkinson, A Shaha
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2010
Oropharyngeal cancer: United Kingdom national multidisciplinary guidelines
H Mehanna, M Evans, M Beasley, S Chatterjee, M Dilkes, J Homer, ...
The Journal of Laryngology & Otology 130 (S2), S90-S96, 2016
Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025
KS Louie, H Mehanna, P Sasieni
Oral oncology 51 (4), 341-348, 2015
Head and neck cancer—Part 2: Treatment and prognostic factors
H Mehanna, CML West, C Nutting, V Paleri
Bmj 341, 2010
The system can't perform the operation now. Try again later.
Articles 1–20